Covid: In search of a new oral antiviral
Reading Time: < 1 minute
Science, Stories and Sevagram: A Physician-Teacher's Reflections
Clinical stories and reflections on evidence-based medicine, research, and patient care.
Reading Time: < 1 minute
Reading Time: < 1 minute
Reading Time: < 1 minute
Reading Time: 2 minutesSome research studies make you sit up and take notice when you eye their titles and read the findings. The Lancet study published on 31 October 2022 is one such. A study everyone entering an OT must read. Why did I like this study? Because, hundreds of thousands of studies are published every year. But … Read more
Reading Time: < 1 minute
Reading Time: < 1 minuteDolo 650. Almost unheard of before Covid hit us, the brand became a name, the country began to associate paracetamol with. Data suggest that the consumption of painkillers shot up by 23% in India last year. Has the pandemic turned us into excessive pill-poppers? Devina Sengupta spoke to me, ET Prime’s Vikas Dandekar and ET’s … Read more
Reading Time: < 1 minuteMolnupiravir. Another drug that has created a lot of hype or hope among public. But does it really deliver what it promises?
Reading Time: < 1 minuteThe ICMR has increasingly drawn criticism from India’s doctors and scientists, who have questioned its drug recommendations & lack of transparency on data related to variants. Countrywide, doctors started writing these prescriptions, which artificially inflated the cost for Covid management,” I said. “Big Pharma was laughing all the way to the bank and ultimately the … Read more
Reading Time: < 1 minuteCovid 19 and children. There is just a one in hundred chance that a child would test positive for Covid and would require a hospital admission.
Reading Time: < 1 minuteHigh hospital bills and black marketing of drugs and oxygen make the treatment of Covid-19 prohibitively expensive. Malini Aisola, co-convenor of the All India Drug Action Network, ET’s Kiran Somvanshi and I discuss the flaws in the existing setup and the steps to fix the financial burden of Covid-19.